Danish Medicines Agency

Theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

Industry

Information on licensing, inspections, fees, company authorisations, clinical trials and more.

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.

Report a side effect from medicines About Brexit International activities Transparency Subscribe to news in English Mission, vision and strategy Telephone directory Whistleblower scheme Jobs 0

News

New criteria for the notification of medicines supply shortages

01 January 0001

The Danish Medicines Agency has established new criteria for when companies must notify medicines supply shortages. The new criteria make it easier for the companies to know when and for which medicinal products they must notify supply shortages, and a new form has made notification even easier.

Henvendelser til Lægemiddelstyrelsen om status på indsendte ansøgninger for lægemidler godkendt via DCP, MRP eller national procedure

26 May 2023

The Danish Medicines Agency suspends the Danish marketing authorisations of four generic medicines

13 December 2022

Recall of the antibiotic Dicillin from Sandoz

06 February 2023